FDA Approves Expanded Indication For Tzield To Delay Type 1 Diabetes In Young Children

“This approval opens an important new chapter in diabetes care for young children with stage 2 type 1 diabetes and their families,” Kimber Simmons, MD, MS, associate professor of pediatrics at the Barbara Davis Center for Diabetes at University of Colorado Anschutz.